75 related articles for article (PubMed ID: 22414543)
1. Catechins containing a galloyl moiety as potential anti-HIV-1 compounds.
Zhao Y; Jiang F; Liu P; Chen W; Yi K
Drug Discov Today; 2012 Jun; 17(11-12):630-5. PubMed ID: 22414543
[TBL] [Abstract][Full Text] [Related]
2. The evaluation of catechins that contain a galloyl moiety as potential HIV-1 integrase inhibitors.
Jiang F; Chen W; Yi K; Wu Z; Si Y; Han W; Zhao Y
Clin Immunol; 2010 Dec; 137(3):347-56. PubMed ID: 20832370
[TBL] [Abstract][Full Text] [Related]
3. How can (-)-epigallocatechin gallate from green tea prevent HIV-1 infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors.
Hamza A; Zhan CG
J Phys Chem B; 2006 Feb; 110(6):2910-7. PubMed ID: 16471901
[TBL] [Abstract][Full Text] [Related]
4. A natural theaflavins preparation inhibits HIV-1 infection by targeting the entry step: potential applications for preventing HIV-1 infection.
Yang J; Li L; Tan S; Jin H; Qiu J; Mao Q; Li R; Xia C; Jiang ZH; Jiang S; Liu S
Fitoterapia; 2012 Mar; 83(2):348-55. PubMed ID: 22155187
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
[TBL] [Abstract][Full Text] [Related]
6. HIV type 1 integrase inhibitors: from basic research to clinical implications.
Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M
AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
[TBL] [Abstract][Full Text] [Related]
7. The anti-HIV activity and mechanisms of action of pure compounds isolated from Rosa damascena.
Mahmood N; Piacente S; Pizza C; Burke A; Khan AI; Hay AJ
Biochem Biophys Res Commun; 1996 Dec; 229(1):73-9. PubMed ID: 8954085
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapy.
Williamson MP; McCormick TG; Nance CL; Shearer WT
J Allergy Clin Immunol; 2006 Dec; 118(6):1369-74. PubMed ID: 17157668
[TBL] [Abstract][Full Text] [Related]
9. Benzophenone glycosides and epicatechin derivatives from Malania oleifera.
Wu XD; Cheng JT; He J; Zhang XJ; Dong LB; Gong X; Song LD; Zheng YT; Peng LY; Zhao QS
Fitoterapia; 2012 Sep; 83(6):1068-71. PubMed ID: 22609684
[TBL] [Abstract][Full Text] [Related]
10. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.
Zhao Q; Ma L; Jiang S; Lu H; Liu S; He Y; Strick N; Neamati N; Debnath AK
Virology; 2005 Sep; 339(2):213-25. PubMed ID: 15996703
[TBL] [Abstract][Full Text] [Related]
11. Tricyclononene carboxamide derivatives as novel anti-HIV-1 agents.
Dong MX; Zhang J; Peng XQ; Lu H; Yun LH; Jiang S; Dai QY
Eur J Med Chem; 2010 Sep; 45(9):4096-103. PubMed ID: 20598780
[TBL] [Abstract][Full Text] [Related]
12. Geometrically and conformationally restrained cinnamoyl compounds as inhibitors of HIV-1 integrase: synthesis, biological evaluation, and molecular modeling.
Artico M; Di Santo R; Costi R; Novellino E; Greco G; Massa S; Tramontano E; Marongiu ME; De Montis A; La Colla P
J Med Chem; 1998 Oct; 41(21):3948-60. PubMed ID: 9767632
[TBL] [Abstract][Full Text] [Related]
13. Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway.
Murase T; Misawa K; Haramizu S; Hase T
Biochem Pharmacol; 2009 Jul; 78(1):78-84. PubMed ID: 19447226
[TBL] [Abstract][Full Text] [Related]
14. [Advances in novel anti-HIV-1 drugs and drug candidates: 2005-2008].
Zheng PR; Xue H; Xiao ZY; Liu G
Yao Xue Xue Bao; 2010 Feb; 45(2):154-64. PubMed ID: 21351426
[TBL] [Abstract][Full Text] [Related]
15. Dimerization inhibitors of HIV-1 reverse transcriptase, protease and integrase: a single mode of inhibition for the three HIV enzymes?
Camarasa MJ; Velázquez S; San-Félix A; Pérez-Pérez MJ; Gago F
Antiviral Res; 2006 Sep; 71(2-3):260-7. PubMed ID: 16872687
[TBL] [Abstract][Full Text] [Related]
16. Structural analogues of the calanolide anti-HIV agents. Modification of the trans-10,11-dimethyldihydropyran-12-ol ring (ring C).
Zembower DE; Liao S; Flavin MT; Xu ZQ; Stup TL; Buckheit RW; Khilevich A; Mar AA; Sheinkman AK
J Med Chem; 1997 Mar; 40(6):1005-17. PubMed ID: 9083491
[TBL] [Abstract][Full Text] [Related]
17. The effect of NNRTIs on HIV reverse transcriptase dimerization.
Tachedjian G; Goff SP
Curr Opin Investig Drugs; 2003 Aug; 4(8):966-73. PubMed ID: 14508881
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of proliferation of human cancer cells and cyclooxygenase enzymes by anthocyanidins and catechins.
Seeram NP; Zhang Y; Nair MG
Nutr Cancer; 2003; 46(1):101-6. PubMed ID: 12925310
[TBL] [Abstract][Full Text] [Related]
19. Functional targeting of the TGF-βR1 kinase domain and downstream signaling: A role for the galloyl moiety of green tea-derived catechins in ES-2 ovarian clear cell carcinoma.
Sicard AA; Suarez NG; Cappadocia L; Annabi B
J Nutr Biochem; 2021 Jan; 87():108518. PubMed ID: 33017609
[TBL] [Abstract][Full Text] [Related]
20. Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching.
Neamati N; Hong H; Mazumder A; Wang S; Sunder S; Nicklaus MC; Milne GW; Proksa B; Pommier Y
J Med Chem; 1997 Mar; 40(6):942-51. PubMed ID: 9083483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
